News

Dr Robert Mutumba, highlighted the high burden of Hepatitis B in Uganda, with children contracting the virus from their mothers ...
A breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines durings the world's most influential meeting on HIV research and its ...
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.
The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...
There are over 100,000 HIV+ Texans. Trump's 'big beautiful' bill would slash funding for federal HIV prevention, medications, ...
The U.N. warned that millions could die as a result of the Trump administration ending nearly $4 billion for the global HIV ...
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions — although it's unclear how many ...
WASHINGTON (AP) -- The U.S. has approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions -- although it's unclear how ...
The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence rates compared to other PrEP medications and with minimal side effects.